Aadi Bioscience, Inc.
US ˙ NasdaqCM ˙ US00032Q1040
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityAADI / Aadi Bioscience, Inc.
InstitutionRenaissance Technologies Llc
ManagerJames Simons
Latest Disclosed Ownership428,622 shares
Latest Disclosed Value $ 1,478,746
Renaissance Technologies Llc reports 2.75% decrease in ownership of AADI / Aadi Bioscience, Inc.

On May 14, 2026 - Renaissance Technologies Llc filed a 13F-HR form disclosing ownership of 428,622 shares of Aadi Bioscience, Inc. (US:AADI) valued at $1,478,746 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 440,722 shares of Aadi Bioscience, Inc.. This represents a change in shares of -2.75% during the quarter. The current value of the position is $878,675 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F WHITEHAWK THERAPEUTICS COM 00032Q104 428,622 -12,100 -2.75 1,479 38.65 0.0023
2026-02-12 2025-12-31 13F WHITEHAWK THERAPEUTICS COM 00032Q104 440,722 -16,700 -3.65 1,067 22.67 0.0017
2025-11-13 2025-09-30 13F WHITEHAWK THERAPEUTICS COM 00032Q104 457,422 -800 -0.17 869 1.52 0.0011
2025-08-13 2025-06-30 13F WHITEHAWK THERAPEUTICS COM 00032Q104 458,222 -3,900 -0.84 857 4.14 0.0011
2025-05-14 2025-03-31 13F WHITEHAWK THERAPEUTICS COM 00032Q104 462,122 6,100 1.34 823 -42.84 0.0012
2025-02-13 2024-12-31 13F AADI BIOSCIENCE COM 00032Q104 456,022 -5,800 -1.26 1,439 51.21 0.0021
2024-11-13 2024-09-30 13F AADI BIOSCIENCE COM 00032Q104 461,822 22,600 5.15 951 48.36 0.0014
2024-08-09 2024-06-30 13F AADI BIOSCIENCE COM 00032Q104 439,222 -104,500 -19.22 641 64,000.00 0.0011
2024-05-13 2024-03-31 13F AADI BIOSCIENCE COM 00032Q104 543,722 145,000 36.37 1 0.0020
2024-02-13 2023-12-31 13F AADI BIOSCIENCE COM 00032Q104 398,722 152,800 62.13 1 -100.00 0.0012
2023-11-14 2023-09-30 13F AADI BIOSCIENCE COM 00032Q104 245,922 41,800 20.48 1 0.00 0.0020
2023-08-11 2023-06-30 13F AADI BIOSCIENCE COM 00032Q104 204,122 -121,602 -37.33 1 -50.00 0.0020
2023-05-12 2023-03-31 13F AADI BIOSCIENCE COM 00032Q104 325,724 74,502 29.66 2 -33.33 0.0031
2023-02-13 2022-12-31 13F AADI BIOSCIENCE COM 00032Q104 251,222 7,300 2.99 3 -99.91 0.0044
2022-11-14 2022-09-30 13F AADI BIOSCIENCE COM 00032Q104 243,922 70,400 40.57 3,447 61.23 0.0049
2022-08-12 2022-06-30 13F AADI BIOSCIENCE COM 00032Q104 173,522 34,000 24.37 2,138 -9.71 0.0025
2022-05-13 2022-03-31 13F AADI BIOSCIENCE COM 00032Q104 139,522 11,000 8.56 2,368 -23.71 0.0028
2022-02-11 2021-12-31 13F AADI BIOSCIENCE COM 00032Q104 128,522 -37,133 -22.42 3,104 -36.20 0.0039
2021-11-12 2021-09-30 13F AADI BIOSCIENCES COM 00032Q104 165,655 165,655 4,865 0.0063
2021-08-13 2021-06-30 13F AERPIO PHARMACEUTICALS COM 00810B105 2,584,347 642,809 33.11 4,368 74.37 0.0055
2021-05-13 2021-03-31 13F AERPIO PHARMACEUTICALS COM 00810B105 1,941,538 142,494 7.92 2,505 42.09 0.0031
2021-02-10 2020-12-31 13F AERPIO PHARMACEUTICALS COM 00810B105 1,799,044 313,860 21.13 1,763 -20.87 0.0019
2020-11-13 2020-09-30 13F AERPIO PHARMACEUTICALS COM 00810B105 1,485,184 -330,691 -18.21 2,228 -1.85 0.0022
2020-08-13 2020-06-30 13F AERPIO PHARMACEUTICALS COM 00810B105 1,815,875 1,364,243 302.07 2,270 815.32 0.0020
2020-05-14 2020-03-31 13F AERPIO PHARMACEUTICALS COM 00810B105 451,632 44,507 10.93 248 -2.36 0.0002
2020-02-13 2019-12-31 13F AERPIO PHARMACEUTICALS COM 00810B105 407,125 246,725 153.82 254 133.03 0.0002
2019-11-13 2019-09-30 13F AERPIO PHARMACEUTICALS COM 00810B105 160,400 97,400 154.60 109 91.23 0.0001
2019-08-12 2019-06-30 13F AERPIO PHARMACEUTICALS COM 00810B105 63,000 63,000 57 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.